Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 5/20 | 0.40 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
| ▸ | ATF4 | P18848 | 3/20 | 0.39 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30026324 | 0.86 | ATF4 (0.55) | HTTMRGPRX4ATF4ADAMTS5 | |
| SCHEMBL19555442 | 0.86 | ATF4 (0.55) | HTTMRGPRX4ATF4ADAMTS5 | |
| SCHEMBL20999266 | 0.86 | ATF4 (0.48) | ATF4GAA | |
| SCHEMBL19569276 | 0.86 | HTT (0.43) | HTTMRGPRX4MAOBMAOAATF4 | |
| SCHEMBL19569277 | 0.84 | HTT (0.44) | HTTMRGPRX4MAOBMAOAATF4 | |
| SCHEMBL19569304 | 0.82 | ATF4 (0.49) | ATF4GAAALOX12 | |
| SCHEMBL30024684 | 0.79 | ATF4 (0.51) | HTTMRGPRX4ATF4 | |
| SCHEMBL19555423 | 0.79 | ATF4 (0.51) | HTTMRGPRX4ATF4 | |
| SCHEMBL19569469 | 0.79 | ATF4 (0.50) | MRGPRX4ATF4 | |
| SCHEMBL30025703 | 0.79 | ATF4 (0.50) | MRGPRX4ATF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200361941-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ABBVIE INC. | 2020-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200361941-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | HTT 2496/4885MRGPRX4 2411/4885MAOB 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.